Cargando…
Defective transcription elongation in a subset of cancers confers immunotherapy resistance
The nature and role of global transcriptional deregulations in cancers are not fully understood. We report that a large proportion of cancers have widespread defects in mRNA transcription elongation (TE). Cancers with TE defects (TE(deff)) display spurious transcription and defective mRNA processing...
Autores principales: | Modur, Vishnu, Singh, Navneet, Mohanty, Vakul, Chung, Eunah, Muhammad, Belal, Choi, Kwangmin, Chen, Xiaoting, Chetal, Kashish, Ratner, Nancy, Salomonis, Nathan, Weirauch, Matthew T., Waltz, Susan, Huang, Gang, Privette-Vinnedge, Lisa, Park, Joo-Seop, Janssen, Edith M., Komurov, Kakajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199328/ https://www.ncbi.nlm.nih.gov/pubmed/30353012 http://dx.doi.org/10.1038/s41467-018-06810-0 |
Ejemplares similares
-
Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022) -
Selective DNA methylation in cancers controls collateral damage induced by large structural variations
por: Mohanty, Vakul, et al.
Publicado: (2016) -
Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability
por: Muhammad, B., et al.
Publicado: (2021) -
Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion
por: Tripathi, Reshmi, et al.
Publicado: (2019) -
Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers
por: Petrany, Michael J., et al.
Publicado: (2020)